AzTrials
AzTrials

Completely EdentulousMCRBNCT02907515

Maintenance and Cost Effectiveness of Cendres Metaux Locator (CM-LOC) Resin Matrix Versus Ball Nylon Matrix Attachment Retaining Single Implant Mandibular Complete Overdentures

A study testing cm-loc attachment and ball attachment in people with Completely Edentulous, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The single implant overdenture (IOD) represent the simplest form of IODs compared to the 2 IOD which is the traditional gold standard IOD treatment option. Mandibular single-implant overdentures are proven to be a successful treatment option for older edentulous adults but we need to know if the CM-LOC attachment will… Read more about this study

Who is it for?
Ages 50 to 69 yearsHealthy volunteers can take part
Conditions the study is for
Completely Edentulous
What is being tested?
cm-loc attachment and ball attachment
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
112 participants
Where
1 siteEgypt
Study dates
Feb 2016to Mar 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 69 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Completely edentulous male or female patients between the ages of 50 to 69.
  • No contraindications for implantation.
  • Each patient has to perform both a random blood sugar and Glycosylated Hemoglobin analysis. Patients with a Glycosylated hemoglobin test HbA1c up to 8% and a normal blood sugar level (79 to 110) or controlled diabetic patients (90-130 fasting according to American Association of Diabetes) will be included.
  • Sufficient bone width (≥ 6 mm) in the anterior region to place an implant. It could be either normally present or achieved by bone plateauing. This will be confirmed by cone beam computed tomographic (CBCT) scans.
  • Residual bone height ranging from 11-20 mm with the lowest vertical height in the midline of the mandible not less than 13 mm (Class II or III according to McGarry et al[1] 1999). This will be confirmed by the CBCT.
  • Patients seeking to install a single symphyseal implant and for whom new dentures will be constructed.
Show all 10Show fewer
  • Patients, who are dissatisfied with the retention and stability of their technically satisfactory dentures.
  • Patients, who already have existing maxillary and mandibular complete dentures, and after examination of the mandibular dentures, it is found that there are technical problems with regard to denture design and/or occlusion; then new maxillary and mandibular dentures will be fabricated
  • All patients should have adapted to their dentures for at least six weeks before being included in the trial.
  • Patients providing written informed consents to participate in the trial and this will be done before the scheduled date for implant installation.

Who cannot join

  • Patients with a systemic or local contra-indication for implant placement.
  • Satisfied patients with the retention of their mandibular denture as well as unsatisfied patients with their maxillary denture.
  • Patient with a mandibular denture height less than 6 mm between the base of the denture and the incisal edge of the central incisors (as measured by a caliper) or with 12 mm crown height space as measured by a ruler from the incisal edge till the crest of the ridge. This will be done from a putty index of the diagnostic set up.
  • Incompliant and not cooperative patients.
  • Patients smoking more than 10 cigarettes per day

Trial locations and contacts

1 site in 1 country.

amr ahmed naguib, ass. lecturer contact

00201000406809

amr_naguib@hotmail.com

Egypt1 site, 1 recruiting
  • Cairo Universty

    Cairo, Cairo Governorate

    cebd, 2364 2938

    Recruiting

Other trials in Egypt

About this study

Official title: Maintenance and Cost Effectiveness of CM-LOC Resin Matrix Versus Ball Nylon Matrix Attachment Retaining Single Implant Mandibular Complete Overdentures

The single implant overdenture (IOD) represent the simplest form of IODs compared to the 2 IOD which is the traditional gold standard IOD treatment option. Mandibular single-implant overdentures are proven to be a successful treatment option for older edentulous adults but we need to know if the CM-LOC attachment will retain its superiority over the ball attachments intraorally regarding the prosthetic complications in single implant retained overdenture like in 2 IOD

Being tested
cm-loc attachment, ball attachment
Keywords
single implant retained mandibular overdenture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cm-loc attachmentDevice

    cm-loc is a new implant attachment mechanism with resin matrix housing to retain the overdenture

  • ball attachmentDevice

    ball attachment is the gold slandered attachment mechanism with nylon cap and metal housing to retain the overdenture

Study groups in NCT02907515
Study groupRoleWhat they receive
cm-loc attachmentExperimentalcm-loc attachment is a new attachment for dental implants and connect to the denture with resin matrix as housing
Receives: Device: cm-loc attachment
ball attachmentActive comparatorball attachment is the most common attachment for dental implants and connect to the denture by nylon cap and metal housing
Receives: Device: ball attachment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. number of prosthodontic Maintenance events

    the number of the patient visits to the doctor to make maintenance for his implant supported overdenture

    Measured: 1 year

Secondary outcomes (1)
  1. cost effectiveness (which treatment will cost less money)

    amount of usa dollars scale spent on either attachment cm-loc or ball attachment in fabrication and maintenance

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Sep 2016 (estimated)
  2. Study startFeb 2016
  3. Primary completionMar 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
112 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02907515
Sponsor's protocol ID
CEBD-CU-2016-09-196
Acronym
MCRB
Status last verified
Sep 2016
First submitted
8 Sep 2016
Last updated
20 Sep 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing cm-loc attachment and ball attachment in people with Completely Edentulous, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact amr ahmed naguib, ass. lecturer (00201000406809, amr_naguib@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

number of prosthodontic Maintenance events (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Sep 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in